| Titan Biotech Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524717 |
NSE Symbol : - |
P/E(TTM) : 40.48 |
|
ISIN Demat : INE150C01011 |
Div & Yield% : 0.20 |
EPS(TTM) : 24.92 |
|
Book Value(₹) : 189.43 |
Market Cap(₹Cr) : 833.64 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 54.35 | 46.50 | 35.17 | 38.28 | 39.89 | 43.11 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 54.35 | 46.50 | 35.17 | 38.28 | 39.89 | 43.11 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.32 | 0.72 | 1.38 | 1.59 | 0.32 | 0.62 |
| Total Income | 55.68 | 47.22 | 36.55 | 39.87 | 40.21 | 43.74 |
| Total Expenditure | 45.03 | 37.76 | 30.60 | 33.43 | 32.13 | 34.87 |
| PBIDT | 10.65 | 9.46 | 5.95 | 6.44 | 8.08 | 8.87 |
| Interest | 0.22 | 0.20 | 0.08 | 0.15 | 0.27 | 0.31 |
| PBDT | 10.43 | 9.26 | 5.87 | 6.29 | 7.81 | 8.56 |
| Depreciation | 1.21 | 1.15 | 0.84 | 1.18 | 1.10 | 1.05 |
| Tax | 2.86 | 1.92 | 1.25 | 1.28 | 1.63 | 1.82 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.50 | 0.03 | 0.02 | 0.03 | 0.08 | 0.00 |
| Reported Profit After Tax | 6.86 | 6.16 | 3.77 | 3.80 | 5.00 | 5.70 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 6.86 | 6.16 | 3.77 | 3.80 | 5.00 | 5.70 |
| EPS (Unit Curr.) | 8.30 | 7.46 | 4.56 | 4.60 | 6.05 | 6.90 |
| EPS (Adj) (Unit Curr.) | 8.30 | 7.46 | 4.56 | 4.60 | 6.05 | 6.90 |
| Calculated EPS (Unit Curr.) | 8.30 | 7.46 | 4.56 | 4.60 | 6.05 | 6.90 |
| Calculated EPS (Adj) (Unit Curr.) | 8.30 | 7.46 | 4.56 | 4.60 | 6.05 | 6.90 |
| Calculated EPS (Ann.) (Unit Curr.) | 33.22 | 29.82 | 18.23 | 18.40 | 24.22 | 27.59 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 33.22 | 29.82 | 18.23 | 18.40 | 24.22 | 27.59 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 8.26 | 8.26 | 8.26 | 8.26 | 8.26 | 8.26 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 19.60 | 20.34 | 16.92 | 16.82 | 20.26 | 20.58 |
| PBDTM(%) | 19.19 | 19.91 | 16.69 | 16.43 | 19.58 | 19.86 |
| PATM(%) | 12.62 | 13.25 | 10.72 | 9.93 | 12.53 | 13.22 |